Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220005194 220002033 0 78 Not known (9) 2014-06-21 2014-06-21 AML17 TRIAL 1 N 220027648 AML17 TRIAL
220005196 220002034 1.61 null Disease modification (D) 2014-12-25 2014-12-28 Cytarabine low (10to20mg/m2) IV/SC 2 N 220027658 CYTARABINE
220005197 220011081 1.62 null Palliative (P) 2014-08-19 2014-08-20 Cytarabine low (10to20mg/m2) IV/SC N N 220027659 CYTARABINE
220005198 220002035 null 84.5 Palliative (P) 2014-12-01 2014-12-01 CYTARABINE N N 220027661 CYTARABINE
220005199 220002035 1.69 null Curative (C) 2013-06-08 2013-06-13 CYTARABINE N N 220027661 CYTARABINE
220005200 220002036 1.88 null Disease modification (D) null 2015-02-03 Cytarabine Low Dose N N 220027663 CYTARABINE
220005201 220002037 0 95.2 Curative (C) 2015-08-11 2015-08-11 Trial Unspecified Y N 220027665 TRIAL
220005202 220002037 null null Curative (C) 2014-08-06 2014-08-06 AML17 TRIAL N Y 220027665 AML17 TRIAL
220005203 220002038 1.88 80 Curative (C) 2017-05-16 2017-05-16 AML17 TRIAL N N 220027667 AML17 TRIAL
220005204 220011084 null 77.3 Curative (C) 2014-08-17 2014-08-17 Trial Unspecified 1 N 220027669 TRIAL
220005208 220002040 1.73 61.4 Curative (C) null 2014-03-21 Trial Unspecified N null 220027684 TRIAL
220005209 220002040 1.65 null Curative (C) 2014-06-26 2014-06-26 Trial Unspecified Y null 220027684 TRIAL
220005210 220002041 null 108.4 Curative (C) 2017-06-20 2017-06-25 Trial Unspecified N N 220027687 TRIAL
220005211 220002041 null 67.5 Palliative (P) 2013-11-10 2013-11-10 Cytarabine Low Dose N N 220027687 CYTARABINE
220005212 220002041 1.7 76 Adjuvant (A) 2014-11-03 2014-11-03 Trial Unspecified Y N 220027687 TRIAL
220005213 220002041 null 100 Curative (C) 2014-04-30 2014-04-30 Trial Unspecified 01 N 220027687 TRIAL
220005214 220002042 null null Palliative (P) 2016-06-06 2016-06-06 Cytarabine low (10to20mg/m2) IV/SC N N 220027692 CYTARABINE
220005215 220002043 null null Disease modification (D) 2017-06-07 2017-06-07 CYTARABINE N null 220027702 CYTARABINE
220005216 220011088 1.69 92 Curative (C) 2015-12-28 2016-01-04 Trial Unspecified Y N 220027703 TRIAL
220005217 220011088 null 82 Curative (C) 2013-10-05 2013-10-05 LI-1 TRIAL 1 null 220027703 TRIAL
220005218 220002044 1.72 121 Curative (C) 2015-09-19 2015-10-01 Trial Unspecified Y N 220027707 TRIAL
220005219 220002044 1.76 null Disease modification (D) 2017-02-26 2017-03-08 Cytarabine Low Dose 2 N 220027707 CYTARABINE
220005220 220002045 null 65.8 Not known (9) 2015-12-26 2015-12-26 AML17 TRIAL 01 null 220027710 AML17 TRIAL
220005221 220002045 1.85 null Disease modification (D) 2017-07-02 2017-07-04 Trial Unspecified 1 null 220027710 TRIAL
220005224 220002047 0 0 Palliative (P) 2013-01-19 2013-01-20 CYTARABINE null null 220027721 CYTARABINE
220005225 220002047 null 82.9 Curative (C) 2017-06-23 2017-06-24 AML17 TRIAL Y null 220027721 AML17 TRIAL
220005226 220002048 1.66 73.8 Curative (C) 2015-03-31 2015-03-31 AML17 TRIAL 02 N 220027724 AML17 TRIAL
220005227 220002048 0 65.8 Curative (C) 2013-09-30 2013-10-03 AML17 TRIAL 01 N 220027724 AML17 TRIAL
220005228 220002048 1.55 50.1 Curative (C) null 2015-02-25 AML17 TRIAL Y null 220027724 AML17 TRIAL
220005230 220002050 1.62 55 Curative (C) 2017-09-18 2017-09-19 AML17 TRIAL Y N 220027730 AML17 TRIAL
220005231 220011094 1.75 95.5 Palliative (P) 2016-05-25 2016-06-03 Trial Unspecified 1 N 220027733 TRIAL
220005232 220011094 1.86 77.2 null 2013-11-02 2013-11-02 AML17 TRIAL Y N 220027733 AML17 TRIAL
220005233 220018732 1.73 null Curative (C) 2013-03-02 2013-03-02 Trial Unspecified 01 N 220027737 TRIAL
220005234 220018732 1.72 73 null 2016-02-01 2016-02-01 Trial Unspecified 01 null 220027737 TRIAL
220005235 220002051 1.63 null Curative (C) null 2016-01-22 AML17 TRIAL null null 220027741 AML17 TRIAL
220005236 220002052 1.73 86 Curative (C) 2016-01-08 2016-01-12 AML17 TRIAL 1 N 220027742 AML17 TRIAL
220005237 220011095 null 0 Palliative (P) 2014-08-15 2014-08-17 Cytarabine Low Dose 02 null 220027747 CYTARABINE
220005238 220011095 1.75 58 Curative (C) 2013-12-01 2013-12-01 CYTARABINE N N 220027747 CYTARABINE
220005239 220002053 null 63 Palliative (P) 2016-07-12 2016-07-12 Cytarabine Low Dose 02 null 220027749 CYTARABINE
220005240 220002053 null 46.8 Curative (C) 2015-10-11 2015-10-12 Cytarabine Low Dose N N 220027749 CYTARABINE
220005241 220002053 1.6 56.2 Curative (C) null 2017-05-10 AML17 TRIAL null null 220027749 AML17 TRIAL
220005242 220002054 1.73 null Disease modification (D) 2014-05-26 2014-05-26 Trial Unspecified 1 N 220027754 TRIAL
220005243 220002055 1.5 68 null 2016-03-22 2016-03-25 AML17 TRIAL Y N 220027755 AML17 TRIAL
220005244 220002056 null null Not known (9) 2017-12-15 2017-12-18 AML17 TRIAL 01 N 220027756 AML17 TRIAL
220005245 220002056 null 97 Palliative (P) 2013-04-09 2013-04-13 Cytarabine Low Dose N N 220027756 CYTARABINE
220005246 220002056 1.86 73.4 Curative (C) 2014-07-08 2014-07-21 Trial Unspecified Y N 220027756 TRIAL
220005247 220002057 1.69 78.8 Curative (C) 2014-07-24 2014-07-24 AML17 TRIAL Y N 220027763 AML17 TRIAL
220005248 220002057 null 100.9 Curative (C) 2014-10-14 2014-10-16 Trial Unspecified 1 null 220027763 TRIAL
220005249 220002058 1.78 83.6 Curative (C) 2017-03-09 2017-03-09 AML17 TRIAL N N 220027770 AML17 TRIAL
220005250 220002058 1.63 77.5 Disease modification (D) 2013-06-22 2013-06-22 Cytarabine Low Dose N N 220027770 CYTARABINE